OA12608A - Process for the isolation of crystalline imiponem. - Google Patents
Process for the isolation of crystalline imiponem. Download PDFInfo
- Publication number
- OA12608A OA12608A OA1200300302A OA1200300302A OA12608A OA 12608 A OA12608 A OA 12608A OA 1200300302 A OA1200300302 A OA 1200300302A OA 1200300302 A OA1200300302 A OA 1200300302A OA 12608 A OA12608 A OA 12608A
- Authority
- OA
- OAPI
- Prior art keywords
- water
- organic solvent
- imipenem
- daim
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN595DE2001 | 2001-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA12608A true OA12608A (en) | 2006-06-08 |
Family
ID=11097062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200300302A OA12608A (en) | 2001-05-18 | 2002-05-20 | Process for the isolation of crystalline imiponem. |
Country Status (17)
Country | Link |
---|---|
US (1) | US7241885B2 (sk) |
EP (1) | EP1395588A4 (sk) |
JP (1) | JP2005514323A (sk) |
KR (1) | KR20040010649A (sk) |
CN (1) | CN1522255A (sk) |
AR (1) | AR036018A1 (sk) |
BR (1) | BR0209844A (sk) |
CA (1) | CA2447673A1 (sk) |
CZ (1) | CZ20033351A3 (sk) |
HU (1) | HUP0501093A2 (sk) |
MX (1) | MXPA03010548A (sk) |
NO (1) | NO20035137D0 (sk) |
OA (1) | OA12608A (sk) |
PL (1) | PL373527A1 (sk) |
SK (1) | SK15092003A3 (sk) |
WO (1) | WO2002094773A2 (sk) |
ZA (1) | ZA200309288B (sk) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0209842A (pt) * | 2001-05-18 | 2005-01-04 | Ranbaxy Lab Ltd | Processo para a preparação de imipenem |
US20040198973A1 (en) * | 2001-08-13 | 2004-10-07 | Tsujii Masahiko | Process for preparation of carbapenem antibiotics |
CN1608066A (zh) * | 2001-11-16 | 2005-04-20 | 兰贝克赛实验室有限公司 | 结晶亚胺培南的制备方法 |
US8293924B2 (en) | 2007-10-08 | 2012-10-23 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of carbapenem antibiotic |
CN103524508B (zh) * | 2013-09-02 | 2016-03-30 | 上海龙翔生物医药开发有限公司 | 一种亚胺培南一水合物的结晶方法 |
CN108623598A (zh) * | 2018-05-21 | 2018-10-09 | 重庆天地药业有限责任公司 | 一种亚胺培南中间体及亚胺培南的制备方法 |
CN113135916A (zh) * | 2020-01-20 | 2021-07-20 | 鲁南制药集团股份有限公司 | 一种亚胺培南制备工艺的除钯方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4138433A (en) * | 1975-06-26 | 1979-02-06 | Hoechst Aktiengesellschaft | Process for preparing 1,2-oxa-phospholanes |
US4194047A (en) | 1975-11-21 | 1980-03-18 | Merck & Co., Inc. | Substituted N-methylene derivatives of thienamycin |
US4081455A (en) * | 1976-06-02 | 1978-03-28 | Pfizer Inc. | 6-Amino-2,2-dimethyl-3-cyanopenams |
US4260543A (en) | 1978-07-03 | 1981-04-07 | Merck & Co., Inc. | Crystalline N-formimidoyl thienamycin |
US4292436A (en) * | 1980-06-25 | 1981-09-29 | Merck & Co., Inc. | Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol |
US4374772A (en) | 1981-03-19 | 1983-02-22 | Merck & Co., Inc. | Process for the preparation of N-formimidoyl thienamycin and reagents therefor |
US4894450A (en) | 1987-05-11 | 1990-01-16 | Merck & Co., Inc. | Process for 2-(aminoalkylthio) carbapenems |
US5245069A (en) * | 1992-10-27 | 1993-09-14 | Merck & Co., Inc. | Process for the preparation of bis(aryl)-phosphorohalidates |
IN191798B (sk) | 2000-11-03 | 2004-01-03 | Ranbaxy Lab Ltd | |
CN1608066A (zh) * | 2001-11-16 | 2005-04-20 | 兰贝克赛实验室有限公司 | 结晶亚胺培南的制备方法 |
-
2002
- 2002-05-20 CA CA002447673A patent/CA2447673A1/en not_active Abandoned
- 2002-05-20 PL PL02373527A patent/PL373527A1/xx not_active Application Discontinuation
- 2002-05-20 AR ARP020101854A patent/AR036018A1/es not_active Application Discontinuation
- 2002-05-20 JP JP2002591446A patent/JP2005514323A/ja not_active Withdrawn
- 2002-05-20 US US10/478,624 patent/US7241885B2/en not_active Expired - Fee Related
- 2002-05-20 MX MXPA03010548A patent/MXPA03010548A/es unknown
- 2002-05-20 HU HU0501093A patent/HUP0501093A2/hu unknown
- 2002-05-20 EP EP02730574A patent/EP1395588A4/en active Pending
- 2002-05-20 CZ CZ20033351A patent/CZ20033351A3/cs unknown
- 2002-05-20 KR KR10-2003-7015043A patent/KR20040010649A/ko not_active Application Discontinuation
- 2002-05-20 OA OA1200300302A patent/OA12608A/en unknown
- 2002-05-20 WO PCT/IB2002/001718 patent/WO2002094773A2/en not_active Application Discontinuation
- 2002-05-20 CN CNA028131207A patent/CN1522255A/zh active Pending
- 2002-05-20 SK SK1509-2003A patent/SK15092003A3/sk not_active Application Discontinuation
- 2002-05-20 BR BR0209844-0A patent/BR0209844A/pt not_active IP Right Cessation
-
2003
- 2003-11-18 NO NO20035137A patent/NO20035137D0/no not_active Application Discontinuation
- 2003-11-28 ZA ZA200309288A patent/ZA200309288B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2447673A1 (en) | 2002-11-28 |
CZ20033351A3 (cs) | 2007-12-27 |
EP1395588A2 (en) | 2004-03-10 |
AR036018A1 (es) | 2004-08-04 |
WO2002094773A2 (en) | 2002-11-28 |
KR20040010649A (ko) | 2004-01-31 |
EP1395588A4 (en) | 2004-09-15 |
JP2005514323A (ja) | 2005-05-19 |
WO2002094773A3 (en) | 2003-10-16 |
SK15092003A3 (sk) | 2004-09-08 |
NO20035137D0 (no) | 2003-11-18 |
CN1522255A (zh) | 2004-08-18 |
ZA200309288B (en) | 2005-02-28 |
MXPA03010548A (es) | 2004-05-27 |
US20040242865A1 (en) | 2004-12-02 |
BR0209844A (pt) | 2005-04-05 |
HUP0501093A2 (en) | 2006-03-28 |
US7241885B2 (en) | 2007-07-10 |
PL373527A1 (en) | 2005-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2601129C (en) | Crystallisation and purification of glycopyrronium bromide | |
US7332600B2 (en) | Process for the preparation of crystalline imipenem | |
EP1776365B1 (en) | Meropenem intermediate in crystalline form | |
MX2011009532A (es) | Metodo mejorado para preparar meropenem usando polvo de zinc. | |
OA12608A (en) | Process for the isolation of crystalline imiponem. | |
KR100364339B1 (ko) | 안정화된 카바페넴 중간체 및 합성적 용도 | |
CA2461565C (en) | Process for making carbapenem compounds | |
US7078534B2 (en) | Process for the preparation of crystalline N-formimidoyl thienamycin monohydrate (imipenem monohydrate) | |
ES2328117T3 (es) | Proceso para la preparacion de imipenem. | |
AU2002302887A1 (en) | Process for the isolation of crystalline imipenem | |
CN100383142C (zh) | 一种制备亚胺培南的方法 | |
WO2012081033A2 (en) | A process for preparation of imipenem | |
KR20130028203A (ko) | 무정형 도리페넴·일수화물의 제조방법 | |
AU2002347451A1 (en) | Process for the preparation of crystalline imipenem | |
EP0883620A1 (en) | Process for the preparation of 2-halomethyl-penems and their use for the preparation of antibacterial penems | |
AU2002302882A1 (en) | Process for the preparation of imipenem |